Global Strategic CDMO & Synthesis Excellence

High-Quality Hot Products Manufacturer & Manufacturers for Israel

Driving Israel's Biomed, Incretin Research, and Clinical Innovation Through Industrial Solid-Phase Peptide Synthesis (SPPS) and Scalable Pharmaceutical APIs.

Send Inquiry Now
Incretin & Metabolic Therapeutic Portfolio

Targeted Peptide API Platforms Serving Israel's Clinical Pipeline

From Tel Aviv biotechnology incubators to advanced academic translational institutions across Rehovot and Haifa, these four hot therapeutic APIs represent our benchmark manufacturing standards in purity, chiral integrity, and endotoxin control.

Macro Ecosystem Dynamics

Israel's Biomedical Ecosystem & Sourcing Imperatives

Israel represents one of the most innovative life sciences, longevity medicine, and pharmacology ecosystems globally. With top-tier academic hubs like the Weizmann Institute of Science, the Technion, and Hadassah Medical Center driving breakthrough pre-clinical translational drug discoveries, the requirement for ultra-high purity peptide drug substances (APIs) and bioactive precursors has never been more urgent.

Israeli pharmaceutical giants, clinical CROs, innovative startups, and aesthetic compounding formulators navigate stringent Israeli Ministry of Health (AMAR/ISRMOH) frameworks. In this rigorous climate, procurement executives cannot afford raw material inconsistencies, unvetted secondary counter-ions, or fragmented delivery timelines.

"The integration of synthetic multi-target incretin analogs (such as GLP-1/GIP/Glucagon pathways) into Israel's metabolic therapeutics and regenerative research landscape demands an unshakeable supply chain anchored in multi-ton synthesis capabilities, strict diastereomeric purity, and robust regulatory documentation."

Our direct manufacturing infrastructure solves the critical procurement pain-points encountered by Israeli enterprises: mitigating single-source vulnerability, accelerating R&D turnaround times from hit-to-lead to Phase I/II campaigns, and guaranteeing full analytical transparency under European/US Pharmacopeia harmonization.

99.5%+
HPLC Analytical Purity Available

Stringent purification via preparative DAC reverse-phase chromatography.

< 10 EU/mg
Bacterial Endotoxin Assurance

Depyrogenated process lines compliant with sterile manufacturing pre-requisites.

Multi-Ton
Annual Solid-Phase Capacity

Redundant glass-lined peptide reactor suites ensuring uninterrupted Israel supply chains.

Factory 4.0 Engineering

Technological Roadmap: Transforming Peptide API Synthesis

By combining automated solid-phase synthesis, green solvent recovery, and AI-directed analytical mapping, our Hangzhou manufacturing center removes the scale limitations that have historically slowed Israeli biomedical and clinical scale-up.

Continuous Flow & Microwave SPPS

We utilize cutting-edge continuous flow synthesis alongside automated Solid-Phase Peptide Synthesis (SPPS). This eliminates aggregation phenomena in difficult, hydrophobic sequences (e.g., Amyloid fragments, Survodutide, and long-chain GLP-1 analogs), slashing coupling times while boosting single-pass conversion yields above 98%.

Preparative DAC Column Purification

Our Dynamic Axial Compression (DAC) high-pressure chromatography systems allow sharp isolation of target peaks from closely eluting deletion sequences (+1/-1 amino acid impurities) and D-enantiomer conformers. This ensures regulatory compliance under Israeli MOH, EMA, and FDA generic drug guidelines.

Counter-Ion Conversion Technology

Recognizing the cellular toxicity risks associated with residual Trifluoroacetic acid (TFA) in pre-clinical models, we offer targeted ion exchange to Acetate (AcOH) or Hydrochloride (HCl) forms, with residual TFA documented below 0.1% or non-detectable levels via specialized ion chromatography.

Accelerate Your Project with Verified Peptide APIs

Whether you require pilot milligram batches for Israeli academic protocols or multi-kilogram commercial lots for therapeutic development, our regulatory team is primed to assist.

Send Inquiry Now
Compliance & Cold Chain Logistics

Localized Logistics, Cold-Chain Integrity & Israeli Regulatory Support

Delivering biologics and peptide materials into Israel requires specialized expertise in customs clearance through Ben Gurion Airport (TLV), climate-controlled logistics, and comprehensive documentation.

Comprehensive CoA

Every batch is backed by RP-HPLC chromatograms, ESI-MS molecular confirmation, water content (Karl Fischer), and net peptide determination.

Validated Cold-Chain

Direct air-express handling with calibrated phase-change packs or dry ice, equipped with continuous temperature loggers to TLV cargo terminals.

Customs Navigation

Accurate HS code declarations, non-hazardous compound affidavits, and research-exemption certificates preventing cargo quarantines.

Israel MOH Support

Regulatory dossiers, impurity qualification data, and residual solvent reports (ICH Q3C) tailored for local pharmaceutical submission.

Procurement & Technical Intelligence

Frequently Asked Technical Questions (Israel Sourcing Guide)

Clear answers addressing the quality attributes, analytical methodologies, and commercial supply terms required by Israeli buyers.

How do you verify the peptide content versus total dry weight?
Peptide purity (determined by RP-HPLC) measures the percentage of the target molecule relative to other peptide-related impurities. In contrast, Net Peptide Content measures the actual mass fraction of peptide present in the lyophilisate, accounting for counter-ions (such as acetate or TFA), residual water, and residual inorganic salts. We verify peptide content via quantitative Nitrogen Elemental Analysis or Amino Acid Analysis (AAA), enabling exact stoichiometric calculations for Israeli formulation teams.
Can you provide peptides with low TFA or complete acetate exchange?
Yes. While standard cleavage from solid supports relies on TFA, which remains bound as a counter-ion, we offer secondary ion-exchange chromatography conversions. We can routinely reduce residual TFA to < 0.1% w/w or substitute it entirely with pharmaceutical-grade acetate or hydrochloride salts, verified by ion-exchange chromatography (IC) and 19F-NMR testing.
What specific documentation accompanies shipments sent to Israeli laboratories?
Each batch shipped to Israel includes a comprehensive, lot-specific Certificate of Analysis (CoA) containing high-resolution RP-HPLC chromatograms (with related substances profiling), Electrospray Ionization Mass Spectrometry (ESI-MS) or MALDI-TOF spectra, Karl Fischer water titration results, residual solvent analysis (ICH Q3C), endotoxin testing results (LAL chromogenic kinetic assay), and a certified statement of origin.
How are sensitive temperature-dependent peptide APIs shipped to Tel Aviv (TLV)?
We partner with validated global biopharma freight forwarders offering expedited cold-chain handling directly to Ben Gurion Airport (TLV). Depending on product stability parameters, consignments are packaged in vacuum-insulated panels (VIP) with either -20°C gel coolants or solid dry-ice charges, monitored by continuous USB/NFC electronic data loggers to prove temperature stability throughout customs clearance.
Do you support custom sequence synthesis and CDMO scale-up for Israeli innovators?
Yes. Through our end-to-end CDMO workflow, we partner with biotechnology innovators and research organizations from milligram-scale exploratory synthesis, route design, and process optimization through to kilogram-scale commercial cGMP manufacturing campaigns.
Initiate Israeli Partner Collaboration

Establish Your Robust, Multi-Ton Peptide API Supply Chain Today

Connect directly with our senior technical desk to review specifications, obtain batch chromatograms, or request custom quotes for Israel distribution.

Send Inquiry Now